BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38356008)

  • 21. The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery.
    Jung TY; Jung S; Ryu HS; Kim IY; Jang WY; Moon KS; Lim SH; Kim DY; Kang SR; Min JJ; Bom HS; Kim SK; Kwon SY
    Stereotact Funct Neurosurg; 2019; 97(4):217-224. PubMed ID: 31694035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma.
    Navarria P; Reggiori G; Pessina F; Ascolese AM; Tomatis S; Mancosu P; Lobefalo F; Clerici E; Lopci E; Bizzi A; Grimaldi M; Chiti A; Simonelli M; Santoro A; Bello L; Scorsetti M
    Radiother Oncol; 2014 Sep; 112(3):425-9. PubMed ID: 25308182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
    Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
    Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
    Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.
    Wu R; Watanabe Y; Arisawa A; Takahashi H; Tanaka H; Fujimoto Y; Watabe T; Isohashi K; Hatazawa J; Tomiyama N
    Jpn J Radiol; 2017 Oct; 35(10):613-621. PubMed ID: 28879406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma.
    Nariai T; Tanaka Y; Wakimoto H; Aoyagi M; Tamaki M; Ishiwata K; Senda M; Ishii K; Hirakawa K; Ohno K
    J Neurosurg; 2005 Sep; 103(3):498-507. PubMed ID: 16235683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
    J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of
    Inoue A; Watanabe H; Kusakabe K; Nishikawa M; Shiraishi Y; Taniwaki M; Takimoto Y; Harada M; Furumochi T; Shigekawa S; Kitazawa R; Kido T; Ohnishi T; Kunieda T
    Neurosurg Rev; 2023 Nov; 46(1):294. PubMed ID: 37925381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.
    Munck Af Rosenschold P; Costa J; Engelholm SA; Lundemann MJ; Law I; Ohlhues L; Engelholm S
    Neuro Oncol; 2015 May; 17(5):757-63. PubMed ID: 25537018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of non- or very subtle contrast-enhancing malignant gliomas with [¹¹C]-methionine positron emission tomography.
    Galldiks N; Kracht LW; Dunkl V; Ullrich RT; Vollmar S; Jacobs AH; Fink GR; Schroeter M
    Mol Imaging; 2011 Dec; 10(6):453-9. PubMed ID: 22201536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sequential analysis of the integrated images of PET, CT and MR in malignant brain tumors before and after radiotherapy].
    Suzuki A; Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Uemura K
    No To Shinkei; 1996 May; 48(5):449-57. PubMed ID: 8672304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.
    Nuutinen J; Sonninen P; Lehikoinen P; Sutinen E; Valavaara R; Eronen E; Norrgård S; Kulmala J; Teräs M; Minn H
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):43-52. PubMed ID: 10924970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
    Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment.
    Minamimoto R; Saginoya T; Kondo C; Tomura N; Ito K; Matsuo Y; Matsunaga S; Shuto T; Akabane A; Miyata Y; Sakai S; Kubota K
    PLoS One; 2015; 10(7):e0132515. PubMed ID: 26167681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
    Pala A; Reske SN; Eberhardt N; Scheuerle A; König R; Schmitz B; Beer AJ; Wirtz CR; Coburger J
    Neurosurg Rev; 2019 Jun; 42(2):471-479. PubMed ID: 29808321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
    Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.
    Weber DC; Zilli T; Buchegger F; Casanova N; Haller G; Rouzaud M; Nouet P; Dipasquale G; Ratib O; Zaidi H; Vees H; Miralbell R
    Radiat Oncol; 2008 Dec; 3():44. PubMed ID: 19108742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.